{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:44:50Z","timestamp":1792025090427,"version":"4.4.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010751","name":"Fondo Nacional de Desarrollo Cient\u00edfico, Tecnol\u00f3gico y de Innovaci\u00f3n Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010751","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Consejo Nacional de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","award":["100-2016-FONDECYT"],"award-info":[{"award-number":["100-2016-FONDECYT"]}]},{"DOI":"10.13039\/100009210","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["HHSF223201510104C"],"award-info":[{"award-number":["HHSF223201510104C"]}],"id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009210","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["HHSF223201710194C"],"award-info":[{"award-number":["HHSF223201710194C"]}],"id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pandemic Institute"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In humans, Ebola virus disease (EVD) has a high mortality rate. While viral load is a known prognostic factor, it is not effective in predicting outcomes across all patients. Exploring host transcriptomic signatures may provide additional predictive value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here, the transcript abundance of 4 candidate host genes (VCAM1, TUBG1, MS4A4A, ISG15) was quantified by reverse transcription quantitative polymerase chain reaction (RT-qPCR) in blood samples from hospitalized patients with Ebola virus (EBOV) collected during the 2013\u20132016 West African outbreak. Samples were taken for diagnostic purposes during the acute phase of infection. Associations between target gene expression, viral load, and outcome (survival\/death) were assessed, and machine learning models were trained and tested to predict patient outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>EBOV cycle threshold (Ct) values were significantly higher in hospitalized survivors compared to fatalities. During the acute phase, the transcript abundance of VCAM1 and MS4A4A was higher in fatal cases, while TUBG1 expression was elevated in survivors; ISG15 expression did not differ by outcome. In support vector machine models, EBOV Ct alone classified patient outcomes with 86.9% accuracy, while MS4A4A alone reached 82.6%. Combining EBOV Ct with MS4A4A improved prediction to 91.3%. The best-performing model, integrating EBOV Ct, ISG15, and MS4A4A, achieved 100% accuracy in the test set.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Host gene expression markers, particularly MS4A4A, in combination with viral load, improved outcome prediction in EVD beyond viral load alone in ambiguous cases with mid-range Ct values. These findings highlight the utility of host transcript-based assays to inform clinical management and for benchmarking the effectiveness of medical countermeasures during outbreaks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiag308","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:30:19Z","timestamp":1781613019000},"page":"e848-e858","source":"Crossref","is-referenced-by-count":0,"title":["Identification of Host Gene Transcripts by Machine Learning and Their Application to Predict Outcome in Ebola Virus Disease"],"prefix":"10.1093","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4887-2786","authenticated-orcid":false,"given":"Jocelyn G","family":"P\u00e9rez","sequence":"first","affiliation":[{"name":"School of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow , Glasgow ,","place":["United Kingdom"]},{"name":"Medical Research Council-University of Glasgow Centre for Virus Research , Glasgow ,","place":["United Kingdom"]},{"name":"Institute of Infection, Veterinary and Ecological Science, Faculty of Health and Life Science, University of Liverpool , Liverpool ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3172-1877","authenticated-orcid":false,"given":"Natasha Y","family":"Rickett","sequence":"additional","affiliation":[{"name":"Institute of Infection, Veterinary and Ecological Science, Faculty of Health and Life Science, University of Liverpool , Liverpool ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6562-0230","authenticated-orcid":false,"given":"Stephan","family":"G\u00fcnther","sequence":"additional","affiliation":[{"name":"Bernhard Nocht Institute for Tropical Medicine , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-8189","authenticated-orcid":false,"given":"Romy","family":"Kerber","sequence":"additional","affiliation":[{"name":"Bernhard Nocht Institute for Tropical Medicine , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa F P","family":"Ng","sequence":"additional","affiliation":[{"name":"A*STAR Infectious Diseases Labs , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3712-415X","authenticated-orcid":false,"given":"Tom","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Liverpool School of Tropical Medicine , Liverpool ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9092-2680","authenticated-orcid":false,"given":"Tracy","family":"MacGill","sequence":"additional","affiliation":[{"name":"Office of Regulatory and Emerging Science, Food and Drug Administration , Silver Spring, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Myers","sequence":"additional","affiliation":[{"name":"Office of Regulatory and Emerging Science, Food and Drug Administration , Silver Spring, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Orr","sequence":"additional","affiliation":[{"name":"Office of Regulatory and Emerging Science, Food and Drug Administration , Silver Spring, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles W","family":"Carroll","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Human Genetics, Nuffield Department of Medicine, Oxford University , Oxford ,","place":["United Kingdom"]},{"name":"Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University , Oxford ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Blake","sequence":"additional","affiliation":[{"name":"Institute of Infection, Veterinary and Ecological Science, Faculty of Health and Life Science, University of Liverpool , Liverpool ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6582-0275","authenticated-orcid":false,"given":"Julian A","family":"Hiscox","sequence":"additional","affiliation":[{"name":"Institute of Infection, Veterinary and Ecological Science, Faculty of Health and Life Science, University of Liverpool , Liverpool ,","place":["United Kingdom"]},{"name":"A*STAR Infectious Diseases Labs , Singapore"},{"name":"The Pandemic Institute , Liverpool ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"2026101419575814700_jiag308-B1","doi-asserted-by":"crossref","first-page":"S250","DOI":"10.1093\/infdis\/jiw269","article-title":"Analysis of diagnostic findings from the European mobile laboratory in Gu\u00e9ck\u00e9dou, Guinea, March 2014 through March 2015","volume":"214","author":"Kerber","year":"2016","journal-title":"J Infect Dis"},{"key":"2026101419575814700_jiag308-B2","doi-asserted-by":"crossref","first-page":"e00325-17","DOI":"10.1128\/mSphereDirect.00325-17","article-title":"Deep sequencing of RNA from blood and oral swab samples reveals the presence of nucleic acid from a number of pathogens in patients with acute Ebola virus disease and is consistent with bacterial translocation across the gut","volume":"2","author":"Carroll","year":"2017","journal-title":"mSphere"},{"key":"2026101419575814700_jiag308-B3","doi-asserted-by":"crossref","first-page":"S496","DOI":"10.1093\/infdis\/jiy429","article-title":"Kinetics of soluble mediators of the host response in Ebola virus disease","volume":"218","author":"Kerber","year":"2018","journal-title":"J Infect Dis"},{"key":"2026101419575814700_jiag308-B4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature17949","article-title":"Unique human immune signature of Ebola virus disease in Guinea","volume":"533","author":"Ruibal","year":"2016","journal-title":"Nature"},{"key":"2026101419575814700_jiag308-B5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13073-020-00811-9","article-title":"Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care","volume":"13","author":"Bosworth","year":"2021","journal-title":"Genome Med"},{"key":"2026101419575814700_jiag308-B6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13059-016-1137-3","article-title":"Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus","volume":"18","author":"Liu","year":"2017","journal-title":"Genome Biol"},{"key":"2026101419575814700_jiag308-B7","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa1411680","article-title":"Clinical illness and outcomes in patients with Ebola in Sierra Leone","volume":"371","author":"Schieffelin","year":"2014","journal-title":"N Engl J Med"},{"key":"2026101419575814700_jiag308-B8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijid.2015.10.021","article-title":"Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients","volume":"42","author":"Li","year":"2016","journal-title":"Int J Infect Dis"},{"key":"2026101419575814700_jiag308-B9","doi-asserted-by":"crossref","first-page":"e0004113","DOI":"10.1371\/journal.pntd.0004113","article-title":"Prognostic analysis of patients with Ebola virus disease","volume":"9","author":"Zhang","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2026101419575814700_jiag308-B10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.eclinm.2019.06.003","article-title":"Machine-learning prognostic models from the 2014\u201316 Ebola outbreak: data-harmonization challenges, validation strategies, and mHealth applications","volume":"11","author":"Colubri","year":"2019","journal-title":"eClinicalMedicine"},{"key":"2026101419575814700_jiag308-B11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/mcpr.2002.0405","article-title":"A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction","volume":"16","author":"Fronhoffs","year":"2002","journal-title":"Mol Cell Probes"},{"key":"2026101419575814700_jiag308-B12","first-page":"614","article-title":"Biostatistics 104: correlational analysis","volume":"44","author":"Chan","year":"2003","journal-title":"Singapore Med J"},{"key":"2026101419575814700_jiag308-B13","first-page":"23","article-title":"Support vector machines the interface to libsvm in package e1071","volume":"1","author":"Meyer","year":"2001","journal-title":"R News"},{"key":"2026101419575814700_jiag308-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models in R using the caret package","volume":"28","author":"Kuhn","year":"2008","journal-title":"J Stat Softw"},{"key":"2026101419575814700_jiag308-B15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.32614\/RJ-2014-008","article-title":"ROSE: a package for binary imbalanced learning","volume":"6","author":"Lunardon","year":"2014","journal-title":"R J"},{"key":"2026101419575814700_jiag308-B16","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ajpath.2020.03.003","article-title":"Quantification of viral and host biomarkers in the liver of rhesus macaques: a longitudinal study of Zaire Ebolavirus Strain Kikwit (EBOV\/Kik)","volume":"190","author":"Greenberg","year":"2020","journal-title":"Am J Pathol"},{"key":"2026101419575814700_jiag308-B17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1186\/s12864-016-3060-0","article-title":"In vivo Ebola virus infection leads to a strong innate response in circulating immune cells","volume":"17","author":"Caballero","year":"2016","journal-title":"BMC Genomics"},{"key":"2026101419575814700_jiag308-B18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/jiz078","article-title":"Laboratory findings, compassionate use of favipiravir, and outcome in patients with Ebola virus disease, Guinea, 2015\u2014a retrospective observational study","volume":"220","author":"Kerber","year":"2019","journal-title":"J Infect Dis"},{"key":"2026101419575814700_jiag308-B19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jinf.2017.12.006","article-title":"Enhanced case management can be delivered for patients with EVD in Africa: experience from a UK military Ebola treatment centre in Sierra Leone","volume":"76","author":"Dickson","year":"2018","journal-title":"J Infect"},{"key":"2026101419575814700_jiag308-B20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201408-1514CP","article-title":"Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa","volume":"190","author":"Fowler","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026101419575814700_jiag308-B21","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3390\/vaccines10081213","article-title":"The evolution of medical countermeasures for Ebola virus disease: lessons learned and next steps","volume":"10","author":"Crozier","year":"2022","journal-title":"Vaccines"},{"key":"2026101419575814700_jiag308-B22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3201\/eid2502.181326","article-title":"Macrophage activation marker soluble CD163 associated with fatal and severe Ebola virus disease in humans","volume":"25","author":"McElroy","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2026101419575814700_jiag308-B23","doi-asserted-by":"crossref","first-page":"e00226-17","DOI":"10.1128\/mBio.00226-17","article-title":"The toll-like receptor 4 antagonist eritoran protects mice from lethal filovirus challenge","volume":"8","author":"Younan","year":"2017","journal-title":"mBio"},{"key":"2026101419575814700_jiag308-B24","doi-asserted-by":"crossref","first-page":"e1005263","DOI":"10.1371\/journal.ppat.1005263","article-title":"Interferon-\u03b3 inhibits Ebola virus infection","volume":"11","author":"Rhein","year":"2015","journal-title":"PLOS Pathog"},{"key":"2026101419575814700_jiag308-B25","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1016\/j.celrep.2020.02.104","article-title":"Acute Plasmodium infection promotes interferon-gamma-dependent resistance to Ebola virus infection","volume":"30","author":"Rogers","year":"2020","journal-title":"Cell Rep"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiag308\/68542825\/jiag308.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/234\/4\/e848\/68542825\/jiag308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/234\/4\/e848\/68542825\/jiag308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:58:07Z","timestamp":1792022287000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/234\/4\/e848\/8709974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,6,17]]},"published-print":{"date-parts":[[2026,10,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiag308","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,15]]},"published":{"date-parts":[[2026,6,17]]}}}